Bixiye
QP75-20 Commercial Pharmacy Benefit Exclusion for Aralast®NP, Eylea®, Glassia®, Lucentis®, Prolastin®-C, and UpliznaTM
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2461 - 2470 ee natiijooyinka 3289
Bixiye
QP70-20 In-Home Test Kits 2020 Program Details for Medicare Advantage and SecureBlue Members
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
P61-20 Site of Service for Selected Outpatient Procedures: XI-03 Medical Policy Update
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2020
Bixiye
P58-20 Hereditary Angioedema (HAE) Drug Prior Authorization Management Changes for generic Icatibant, Firazyr, Haegarda, and Takhzyro — Effective October 5, 2020
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2020
Bixiye
P56-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective October 5, 2020
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2020
Bixiye
P59-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2020
Bixiye
P60-20 Lab Management CPT Codes added by the American Medical Association (AMA) and eviCore Healthcare Specialty Utilization Management (UM) Program Updates
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2020
Bixiye
P54-20 Documentation Requirements for Replacement Claims
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2020
Bixiye
2020 August Bulletins
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2020
Bixiye
P62-20 CMS Decision on Acupuncture for Chronic Low Back Pain
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2020